News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,567 Results
Type
Article (1969)
Company Profile (2)
Press Release (67596)
Section
Business (21543)
Career Advice (9)
Deals (4565)
Drug Development (8165)
FDA (1805)
Job Trends (807)
News (37098)
Policy (3561)
Tag
Academia (93)
Alliances (8146)
Alzheimer's disease (121)
Antibody-drug conjugate (ADC) (10)
Approvals (1824)
Artificial intelligence (13)
Bankruptcy (9)
Best Places to Work (590)
Biosimilars (15)
Breast cancer (15)
Cancer (168)
Career advice (9)
Cell therapy (17)
Clinical research (6954)
Collaboration (69)
COVID-19 (185)
C-suite (10)
Data (144)
Diabetes (11)
Diagnostics (595)
Drug discovery (12)
Duchenne muscular dystrophy (7)
Earnings (7545)
Events (6932)
Executive appointments (41)
FDA (1907)
Funding (46)
Gene therapy (14)
GLP-1 (41)
Government (233)
Healthcare (1078)
Infectious disease (190)
Inflammatory bowel disease (15)
Intellectual property (8)
IPO (1627)
Job creations (240)
Job search strategy (9)
Layoffs (9)
Legal (948)
Liver cancer (15)
Lung cancer (27)
Lymphoma (10)
Manufacturing (25)
Medical device (1112)
Medtech (1113)
Mergers & acquisitions (3011)
Metabolic disorders (34)
Neuroscience (155)
NextGen: Class of 2025 (224)
Non-profit (62)
Northern California (115)
Obesity (15)
Ovarian cancer (7)
Pancreatic cancer (6)
Parkinson's disease (12)
Patents (13)
People (4955)
Phase I (1890)
Phase II (2907)
Phase III (2643)
Pipeline (67)
Postmarket research (241)
Preclinical (655)
Radiopharmaceuticals (22)
Rare diseases (22)
Real estate (603)
Regulatory (2560)
Research institute (92)
Schizophrenia (6)
Series A (11)
Southern California (113)
Startups (428)
United States (1023)
Vaccines (20)
Date
Today (10)
Last 7 days (49)
Last 30 days (203)
Last 365 days (3186)
2025 (328)
2024 (3280)
2023 (3843)
2022 (7047)
2021 (6405)
2020 (5879)
2019 (3875)
2018 (3019)
2017 (3565)
2016 (3171)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (79)
Arizona (7)
Asia (21257)
Australia (2425)
California (265)
Canada (194)
China (124)
Connecticut (14)
Europe (12421)
Florida (15)
Illinois (16)
India (8)
Japan (58)
Maryland (66)
Massachusetts (187)
Minnesota (25)
New Jersey (145)
New York (118)
North Carolina (53)
Northern California (115)
Pennsylvania (38)
South America (105)
Southern California (113)
Texas (18)
Utah (14)
Virginia (15)
69,567 Results for "exscientia ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Exscientia to Present at Upcoming Investor Conferences in June
Exscientia plc (Nasdaq: EXAI) today announced that members of Exscientia management will participate in the following upcoming investor conferences in June.
May 30, 2024
·
1 min read
Press Releases
Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration
October 16, 2024
·
5 min read
Business
Exscientia to Report First Quarter 2024 Financial Results on May 21, 2024
Exscientia plc (Nasdaq: EXAI) will report financial results for the first quarter ended March 31, 2024, on Tuesday, May 21, 2024, before the open of U.S. markets.
May 14, 2024
·
1 min read
Business
Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme
Exscientia plc announced that Sanofi is adding a new discovery stage programme identified and initially advanced by Exscientia into the current collaboration.
December 21, 2023
·
3 min read
Business
Exscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in Oncology
Exscientia plc (Nasdaq: EXAI) today announced the appointment of two technology and clinical development leaders to senior roles to significantly strengthen the impact of differentiating technology applications as well as focused oncology pipeline development.
June 6, 2024
·
6 min read
Exscientia to Present at Upcoming Investor Conferences in March - February 28, 2024
Exscientia plc (Nasdaq: EXAI) today announced that members of management will participate in the following upcoming investor conferences in March.
February 28, 2024
·
1 min read
Business
Exscientia Business and Financial Update for the Full Year 2023
Recent advancements in the Company’s pipeline, collaborations and operations, as well as financial results for the fourth quarter and full year 2023, are summarised below. Exscientia will host a conference call Thursday, March 21 at 12:30 p.m. GMT / 8:30 a.m. EDT.
March 21, 2024
·
12 min read
Mergers & acquisitions
Recursion, Exscientia Merge to Create AI-Enabled Biotech
Armed with a combined $850 million in cash, the companies said Thursday the resulting biotech will have a pipeline that could deliver 10 clinical readouts over the next 18 months.
August 8, 2024
·
2 min read
·
Nick Paul Taylor
Press Releases
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024
October 9, 2024
·
6 min read
Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference
Exscientia plc (Nasdaq: EXAI) today announced that members of Exscientia management will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023, at 3:25 p.m. EST (8:25 p.m. GMT).
November 21, 2023
·
1 min read
1 of 6,957
Next
